William Ardrey
Director/Board Member bei Resistys, Inc.
Profil
William J. Ardrey ist ein Geschäftsmann, der bereits 12 verschiedene Unternehmen geleitet hat. Dr. Ardrey ist im Vorstand von Resistys, Inc. und Professor an der University of Adelaide, Professor an der George Washington University, Professor an der University of Western Australia und Professor an der Columbia University. In seiner bisherigen Laufbahn hatte William J. Ardrey die Position des Chairman, President & Chief Executive Officer bei Avantogen Oncology, Inc. inne, des Chief Executive Officer bei Alcon, Inc. des President & Non-Executive Director bei CustomVis Plc, des President von LaserSight, Inc. des Chief Executive Officer für SciClone Pharmaceuticals, Inc, Präsident bei Thomson Financial Services LLC, Vorsitzender bei Solbec Pharmaceuticals Ltd, Chief Executive Officer bei Novartis, Inc, Chief Executive Officer bei Acuvax Ltd, Präsident bei Regenera Ltd, Chief Executive Officer bei QLT, Inc. und Chief Executive Officer bei Avantogen Ltd.
Aktive Positionen von William Ardrey
| Unternehmen | Position | Beginn |
|---|---|---|
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | 20.04.2009 |
| George Washington University | Corporate Officer/Principal | 20.04.2009 |
| University of Adelaide | Corporate Officer/Principal | 20.04.2009 |
Resistys, Inc.
 Resistys, Inc. Pharmaceuticals: MajorHealth Technology Part of Avantogen Oncology, Inc., Resistys, Inc. develops RP101, a pancreatic cancer drug aimed at preventing chemo-resistance for the North American market. The private company is based in Los Angeles, CA. | Director/Board Member | 06.12.2010 |
| The University of Western Australia | Corporate Officer/Principal | 16.09.2011 |
Ehemalige bekannte Positionen von William Ardrey
| Unternehmen | Position | Ende |
|---|---|---|
Acuvax Ltd.
 Acuvax Ltd. Pharmaceuticals: OtherHealth Technology Acuvax Ltd. is engaged in the research and development of cancer therapies and virus and vaccine development in Australia and North America. It is in process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers. The company is headquartered in West Perth, Australia. | President | 09.02.2011 |
| Solbec Pharmaceuticals Ltd. | Chairman | 08.12.2008 |
CustomVis Plc
 CustomVis Plc Medical SpecialtiesHealth Technology CustomVis Plc manufactured and sold laser optical equipment for use within the laser vision correction industry. The company's products included CustomVisTM and PULZAR Z1TM. It was founded in March 2001 and headquartered in Perth, Australia. | President | 22.05.2006 |
| Avantogen Ltd. | President | - |
| ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALCON INC. | Health Technology |
| Private Unternehmen | 13 |
|---|---|
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology SciClone Pharmaceuticals LLC was engaged in the development of therapeutic treatment for oncology, infectious diseases, and cardiovascular disorders. It was also offering ZADAXIN for the treatment of hepatitis B, hepatitis C, certain cancers, and used as immune system enhancer, and DC Bead which is used for the novel treatment of liver cancer. The company was founded in 1990 and was headquartered in San Mateo, CA. | Health Technology |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
LaserSight, Inc.
 LaserSight, Inc. Electronic ComponentsElectronic Technology LaserSight, Inc. through its wholly-owned operating subsidiaries LaserSight Technologies, Inc. and LaserSight Patents, Inc engages in the development, manufacture & sale of ophthalmic lasers and related products primarily for use in laser vision correction, including laser in-situ keratomileusis & photorefractive keratectomy procedures. It also licenses patents related to refractive surgical procedures. The company was founded in 1987 and is headquartered in Winter Park, FL. | Electronic Technology |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
Hawaii Biotech, Inc.
 Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | Health Technology |
CustomVis Plc
CustomVis Plc Medical SpecialtiesHealth Technology CustomVis Plc manufactured and sold laser optical equipment for use within the laser vision correction industry. The company's products included CustomVisTM and PULZAR Z1TM. It was founded in March 2001 and headquartered in Perth, Australia. | Health Technology |
| Solbec Pharmaceuticals Ltd. | Health Technology |
Acuvax Ltd.
Acuvax Ltd. Pharmaceuticals: OtherHealth Technology Acuvax Ltd. is engaged in the research and development of cancer therapies and virus and vaccine development in Australia and North America. It is in process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers. The company is headquartered in West Perth, Australia. | Health Technology |
| Regenera Ltd. | Commercial Services |
Resistys, Inc.
Resistys, Inc. Pharmaceuticals: MajorHealth Technology Part of Avantogen Oncology, Inc., Resistys, Inc. develops RP101, a pancreatic cancer drug aimed at preventing chemo-resistance for the North American market. The private company is based in Los Angeles, CA. | Health Technology |
Avantogen Oncology, Inc.
 Avantogen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Avantogen Oncology, Inc. operates as a development stage company. It is engaged in the acquisition and development of novel compounds to treat patients with various types of cancer. The company was founded in 1986 and is headquartered in Pasadena, CA. | Health Technology |
| Avantogen Ltd. | Commercial Services |
Thomson Financial Services LLC
 Thomson Financial Services LLC Life/Health InsuranceFinance Thomson Financial Services LLC offers insurance services. The firm assists employees on claim issues and educate on benefits of policies. It offers medical, dental, life, disability, and long term insurance services. The company is headquartered in Southington, CT. | Finance |
